TNPSC Thervupettagam

Sputnik V

April 15 , 2021 1318 days 963 0
  • The Drugs Controller General of India has approved emergency use authorisation of the Russian Vaccine, Sputnik V.
  • It has now become the third vaccine to get emergency use authorisation from the drug regulator after Covishield and Covaxin.
  • It was discussed in the meeting of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).
  • It was chaired by VK Paul, Member (Health), Niti Aayog.
  • Sputnik Vaccine was developed by Russia in the last year.
  • India is the most populated country to register the Russian vaccine.
  • India has now become the 60th country to approve Sputnik V.
  • India is also the leading production hub for Sputnik V.
  • The Hyderabad based Indian pharma company Dr Reddy’s Lab has also inked an agreement with Russia for the supply of this vaccine in India.
  • Russia is the first country in the world to register a vaccine against Coronavirus (August 2020).

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories